Giorgio Ottaviani
InvestorHead of Communications, Americas at Warburg Pincus · Operating Partner at Versant Ventures
About
Operating Partner at Versant and SVP of Preclinical Development at the firm's Ridgeline Discovery Engine, with drug development expertise. He joined Ridgeline in 2018 from Roche, where he led DMPK-PD project leaders and headed non-clinical safety in Shanghai, and previously worked at Novartis and Merck-Serono. He holds a Ph.D. in Pharmaceutical Chemistry from the University of Geneva and is a certified toxicologist (DABT).
Colleagues at Warburg Pincus
Alexi Baker
Director at Warburg Pincus
Alice Gibb
Europe Communications Director at Warburg Pincus
Anna Bansal
Analyst at Warburg Pincus
Arjun Murti
Investor at Veriten
Balakrishnan V
Chairman at Exfinity Ventures
Bryan Ang
Associate at Warburg Pincus
Carlos Pinto
Analyst at Warburg Pincus
Christine Fuchs
Board Member at Launchpad Venture Group
Frequently asked questions
- Who is Giorgio Ottaviani?
- Operating Partner at Versant and SVP of Preclinical Development at the firm's Ridgeline Discovery Engine, with drug development expertise. He joined Ridgeline in 2018 from Roche, where he led DMPK-PD project leaders and headed non-clinical safety in Shanghai, and previously worked at Novartis and Merck-Serono. He holds a Ph.D. in Pharmaceutical Chemistry from the University of Geneva and is a certified toxicologist (DABT).
- Where does Giorgio Ottaviani work?
- Giorgio Ottaviani is Head of Communications, Americas at Warburg Pincus.